Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

JL Price, DW McKeel Jr, VD Buckles, CM Roe… - Neurobiology of …, 2009 - Elsevier
JL Price, DW McKeel Jr, VD Buckles, CM Roe, C Xiong, M Grundman, LA Hansen…
Neurobiology of aging, 2009Elsevier
OBJECTIVE: To determine the frequency and possible cognitive effect of histological
Alzheimer's disease (AD) in autopsied older nondemented individuals. DESIGN: Senile
plaques (SPs) and neurofibrillary tangles (NFTs) were assessed quantitatively in 97 cases
from 7 Alzheimer's Disease Centers (ADCs). Neuropathological diagnoses of AD (npAD)
were also made with four sets of criteria. Adjusted linear mixed models tested differences
between participants with and without npAD on the quantitative neuropathology measures …
OBJECTIVE
To determine the frequency and possible cognitive effect of histological Alzheimer's disease (AD) in autopsied older nondemented individuals.
DESIGN
Senile plaques (SPs) and neurofibrillary tangles (NFTs) were assessed quantitatively in 97 cases from 7 Alzheimer's Disease Centers (ADCs). Neuropathological diagnoses of AD (npAD) were also made with four sets of criteria. Adjusted linear mixed models tested differences between participants with and without npAD on the quantitative neuropathology measures and psychometric test scores prior to death. Spearman rank-order correlations between AD lesions and psychometric scores at last assessment were calculated for cases with pathology in particular regions.
SETTING
Washington University Alzheimer's Disease Research Center.
PARTICIPANTS
Ninety-seven nondemented participants who were age 60 years or older at death (mean=84 years).
RESULTS
About 40% of nondemented individuals met at least some level of criteria for npAD; when strict criteria were used, about 20% of cases had npAD. Substantial overlap of Braak neurofibrillary stages occurred between npAD and no-npAD cases. Although there was no measurable cognitive impairment prior to death for either the no-npAD or npAD groups, cognitive function in nondemented aging appears to be degraded by the presence of NFTs and SPs.
CONCLUSIONS
Neuropathological processes related to AD in persons without dementia appear to be associated with subtle cognitive dysfunction and may represent a preclinical stage of the illness. By age 80–85 years, many nondemented older adults have substantial AD pathology.
Elsevier